It has been shown in in vivo experiments that the activation of the RAS-RAF-MEK-ERK pathway in HCL patients is mediated by the expression of cyclin D1 and the ERK protein in hairy cells of the bone marrow (11, 17). The gene discussed is MAPK1; the disease is hairy cell leukemia.